Her 2 and Her 3 signalling and Dr M Moasser

[Ellie F]

Lani-just wanted to say many thanks for keeping us so well informed.

What I seem to have gathered so far is that it is thought that there are many sub-groups within her2 bc (let alone all the other types).At present we do not have sophisticated assessment tools for us to be able to determine all of these sub types and even less idea which combination of drugs will be effective (assuming that we have discovered enough drugs to treat all sub types!) The result seems to be pick and mix of chemos for advanced breast cancer (and some early stage).
I remember a famous onc from MSKCC talking about needing to use good scientific analysis with a mathematical model to determine individual treatment regimes. Why are we still so far away from this???

Ellie